Multidose PK Study of Staccato Loxapine - Contacts and Locations

Home

Multidose PK Study of Staccato Loxapine

This study has been completed.

Study NCT00555412. Last updated on June 2, 2008. Information provided by Alexza Pharmaceuticals, Inc.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00555412

Locations


United States, Georgia
	Atlanta Center for Medical Research
	Atlanta, Georgia, United States, 30308

Sponsors and Collaborators

Alexza Pharmaceuticals, Inc.

Investigators


Principal Investigator:	Robert Riesenberg, MD	Atlanta Center for Medical Research